Press Release

Nasal Sprays Market Size, Share and Global Trend, Overview by Segmentation and Key Players | ADAPT Pharma, Inc., Egalet Corporation and more

Nasal Sprays Market Size, Top 3 Players Operating Players | ADAPT Pharma, Inc., Egalet Corporation, GlaxoSmithKline plc. and more

The Global Nasal Sprays Market is slated to witness accelerated growth with increasing regulatory approvals for newer products. According to a report by Fortune Business Insights, titled “Nasal Spray Market Size, Share and Global Trend By Type (Salt Water Solutions, Decongestants, Steroid, Antihistamine), By Application (Asthma, Cold, Nasal Allergies), By Patient Type Infant, Paediatric, Adults), By End User (Hospitals, Clinics, Ambulatory Surgery Centres, Home Care Settings) Geography Forecast till 2026,” the market is likely to surge in the coming years with encouragement from increasing FDA approval of newer products.

Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-spray-market-100273

Some of the major companies that are present in the Global Nasal Spray Market are

  • ADAPT Pharma
  • Egalet Corporation
  • GSK
  • ARIUS FORMULATIONS PVT LTD.
  • Renatu
  • Bayer
  • J Pharmaceuticals
  • AURENA Laboratories AB
  • Cipla
  • INNOVUS PHARMACEUTICALS, INC.
  • Sandoz International GmbH
  • Leeford Healthcare Limited
  • ALLERGAN
  • Sunovion Pharmaceuticals
  • Nephron Pharmaceuticals
  • Mylan N.V

FDA Approves Janssen’s nasal spray ‘Spravato’

In March 2019, the US Food and Drug Administration (USFDA) passed a usage approval for “Spravato”. Janssen’s Spravato was a fast processing antidepressant drug. The approval has encouraged Janssen’s counterparts and many have been encouraged to introduce newer products. Spravato was a product with high efficacy and much reduced side effects. The approval for Spravato will have a positive impact on the global market and is likely to favor the growth of the market in the coming years.

Increasing Incidence of Allergic Rhinitis to Lead to Increased Demand

According to the Australian Institute of Health and Welfare, in 2014, around 4.5 million people suffered from allergic rhinitis in Australia. Certain indications of allergic rhinitis such as fever, cold and bad breath can be overcome using nasal sprays. A high prevalence of nasal disorders and allergies is likely to cause an increased adoption of nasal sprays, globally. The increased adoption may have a positive impact on the global market and are likely to favor growth of the market in the coming years.

Browse Complete Report Details at:

https://www.fortunebusinessinsights.com/industry-reports/nasal-spray-market-100273

As per a study by the Food and Drug Administration (FDA), in 2018, around 7.4 million adults in the U.S suffer from treatment-resistant depression. Increasing prevalence of this disorder may lead to increased chances of suicidal tendencies and hospitalization. Increasing hospitalization may lead to further demand for nasal sprays and thereby, enable growth of the global nasal sprays market in the forthcoming years.

Painless drug delivery modes are a major factor that may favor the growth of the global nasal sprays market. Additionally, ease of availability and improved patient convenience are other factors that may boost the market in coming years. Having said that, certain adverse reactions of nasal spray and side effects such as nasal dryness, congestion and inflammation may hamper the growth of the global nasal sprays market in the coming years.

View Related Reports:

Tags

Jesus Rust

Jesus is leading the environment column. He is a very renowned environmentalist and has worked in many projects, some of which are based in faraway lands too. He always encourages environment conservation and sometimes keeps small group talks about the concerns. His writing and editing skills act the cheery on the top of the cake.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close